Nomura Asset Management Co. Ltd. raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 69.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 408,265 shares of the healthcare conglomerate’s stock after buying an additional 166,866 shares during the period. UnitedHealth Group makes up approximately 0.9% of Nomura Asset Management Co. Ltd.’s investment portfolio, making the stock its 18th largest position. Nomura Asset Management Co. Ltd.’s holdings in UnitedHealth Group were worth $66,960,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. State Street Corp raised its position in shares of UnitedHealth Group by 2.5% in the first quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock valued at $7,499,276,000 after buying an additional 1,122,534 shares in the last quarter. Ameriprise Financial Inc. raised its position in shares of UnitedHealth Group by 29.9% in the first quarter. Ameriprise Financial Inc. now owns 3,332,761 shares of the healthcare conglomerate’s stock valued at $546,574,000 after buying an additional 766,573 shares in the last quarter. Swiss National Bank raised its position in shares of UnitedHealth Group by 25.8% in the first quarter. Swiss National Bank now owns 3,719,488 shares of the healthcare conglomerate’s stock valued at $610,033,000 after buying an additional 763,161 shares in the last quarter. Karp Capital Management Corp acquired a new position in shares of UnitedHealth Group during the first quarter valued at $113,729,000. Finally, Old Mutual Global Investors UK Ltd. acquired a new position in shares of UnitedHealth Group during the first quarter valued at $109,807,000. Institutional investors and hedge funds own 86.21% of the company’s stock.

UnitedHealth Group Incorporated (NYSE UNH) traded down 0.98% on Friday, reaching $190.82. 2,858,501 shares of the company were exchanged. The company’s 50-day moving average price is $190.49 and its 200-day moving average price is $175.87. UnitedHealth Group Incorporated has a 12-month low of $132.39 and a 12-month high of $196.04. The stock has a market capitalization of $184.50 billion, a P/E ratio of 22.92 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The firm had revenue of $50.05 billion for the quarter, compared to the consensus estimate of $49.97 billion. During the same quarter in the prior year, the company posted $1.96 earnings per share. The business’s revenue was up 7.7% on a year-over-year basis. Equities research analysts anticipate that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th will be issued a dividend of $0.75 per share. The ex-dividend date is Thursday, September 7th. This represents a $3.00 annualized dividend and a yield of 1.57%. UnitedHealth Group’s payout ratio is 35.13%.

TRADEMARK VIOLATION WARNING: “UnitedHealth Group Incorporated (UNH) Shares Bought by Nomura Asset Management Co. Ltd.” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this story can be read at https://www.thecerbatgem.com/2017/08/20/unitedhealth-group-incorporated-unh-shares-bought-by-nomura-asset-management-co-ltd.html.

UNH has been the topic of several analyst reports. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Friday, May 19th. Deutsche Bank AG restated a “buy” rating and issued a $187.00 price objective (up from $183.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Cantor Fitzgerald restated an “overweight” rating and issued a $208.00 price objective on shares of UnitedHealth Group in a report on Friday, July 21st. Vetr upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $186.50 price objective on the stock in a report on Tuesday, May 30th. Finally, CIBC increased their price objective on shares of UnitedHealth Group from $186.00 to $187.00 and gave the company an “outperform” rating in a report on Monday, April 24th. One equities research analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the company. UnitedHealth Group has an average rating of “Buy” and an average target price of $203.41.

In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of $182.64, for a total transaction of $913,200.00. Following the transaction, the director now owns 75,735 shares in the company, valued at $13,832,240.40. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Gail R. Wilensky sold 5,540 shares of the company’s stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total transaction of $990,219.60. Following the transaction, the director now owns 60,516 shares in the company, valued at approximately $10,816,629.84. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,540 shares of company stock worth $2,873,320. Corporate insiders own 0.89% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.